Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19

Ann Intern Med. 2023 Feb;176(2):eL220456. doi: 10.7326/L22-0456.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adult
  • COVID-19*
  • Hospitalization
  • Humans
  • Recombinant Fusion Proteins
  • SARS-CoV-2

Substances

  • ensovibep
  • Recombinant Fusion Proteins